Skip to main content
. 2021 Apr 29;24:1012–1023. doi: 10.1016/j.omtn.2021.04.007

Figure 1.

Figure 1

ILF3-AS1 and EZH2 raise, whereas CDKN2A reduces in CRC tissues and cells

(A) Expression of ILF3-AS1 in CRC tissues and adjacent tissues. (B) Expression of EZH2 mRNA in CRC tissues and adjacent tissues. (C) Expression of CDKN2A mRNA in CRC tissues and adjacent tissues. (D) Protein bands of EZH2 and CDKN2A in CRC tissues and adjacent tissues. (E) Comparison of EZH2 and CDKN2A protein expression in CRC tissues and adjacent tissues. (F) Correlation between the expression of ILF3-AS1 and EZH2 in CRC patients by Pearson test. (G) Correlation between the expression of ILF3-AS1 and CDKN2A in CRC patients by Pearson test. (H) Correlation between the expression of EZH2 and CDKN2A in CRC patients by Pearson test. (I) ILF3-AS1 and CDKN2A expression in NCM460 cells and CRC cell lines. (J) Protein bands of EZH2 and CDKN2A in NCM460 cells and CRC cell lines. (K) EZH2 and CDKN2A protein expression in NCM460 cells and CRC cell lines. Comparisons between two groups were formulated by independent sample t test, whereas comparisons among multiple groups were assessed by one-way ANOVA, followed by Tukey’s multiple comparisons test for pairwise comparison. ∗p < 0.05 versus adjacent tissues, ˆp < 0.05 versus NCM460 cells.